warning icon

COVID-19 DEW Report, powered by Reformulary®Read more

close

Latest From the
world of Reformulary

Meet the Experts: Tumour Agnostic Therapies with Dr. Bill Evans
 
Learn More
Canada has two systems for cannabis use, but they’re at risk of blending into one
 
Learn More
Cannabis Standard Insights, Issue #3 published by Reformulary Group
 
Learn More
Reformulary Group announces partnership with Data Fabric platform Cinchy
 
Learn More
Reformulary Group announces pilot of productivity tool for cannabis and other medicines
 
Learn More
Reformulary Group launches drug coverage exception process
 
Learn More
Cannabis Standard Index brings much-needed clarity to medical cannabis
 
Learn More
Reformulary Group announces preferred pharmacy partnership with Rexall
 
Learn More
Reformulary Group launches Quality of Life tool for prescription drugs and cannabis
 
Learn More
Reformulary Group joins BlackNorth Initiative to combat anti-black racism in Canadian business
 
Learn More
Reformulary Group Announces Partnership with VIVO Cannabis
 
Learn More
Reformulary Group launches COVID-19 DEW Report
 
Learn More